Antimicrobial susceptibilities and beta-lactamase production of Shigella isolates in Crete, Greece, during the period 1991-1995

APMIS

Volumn 106, Issue 9, 1998, Pages 879-883

  Maraki, S ^a,b   Georgiladakis, A ^a   Christidou, A ^a   Scoulica, E ^a   Tselentis, Y ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^b NONE   (Greece)

Author keywords

Antibiotic susceptibility; Shigella; lactamases

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAMASE; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTIBUTEN; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; GENE SEQUENCE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SHIGELLA; SHIGELLA FLEXNERI; SHIGELLA SONNEI;

EID: 0031752612     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1699-0463.1998.tb00234.x     Document Type: Article

References (32)

1. Arora, D. R., Midha, N. K., Ichhpujani, R. L. & Chugh, T. D.: Drug resistant shigellosis in north India. Indian J. Med. Res. 76: 74-79, 1982.
2. Ashkenazi, S., Amir, J. Y., Waisman, Y., Rachmel, A., Garty, B., Samra, Z., Varsano, I. & Nitzan, M.: A randomized, double blind study comparing cefixime and trimethoprim-sulfameth-oxazole in the treatment of childhood shigellosis. J. Pediatr. 123: 817-821, 1993.
3. Ashkenazi, S., May-Zahav, M., Sulkes, J., Zilberberg, R. & Samra, Z.: Increasing antimicrobial resistance of Shigella isolates in Israel during the period 1984 to 1992. Antimicrob. Agents Chemother. 39: 819-823, 1995.
4. Barthelemy, M., Guionie, M. & Labia, R.: Beta-lactamases: determination of their isoelectric points. Antimicrob. Agents Chemother. 13: 695-698, 1978.
5. Bennish, M., Eusof, A., Kay, B. & Wierzba, T.: Multiresistant Shigella infections in Bangladesh. Lancet ii: 441, 1985 (Letter).
6. Bennish, M. L., Salam, M. A., Haider, R. & Barza, M.: Therapy for shigellosis. II. Randomized, double-blind comparison of ciprofloxacin and ampicillin. J. Infect. Dis. 162: 711-716, 1990.
7. Bennish, M. L., Salam, M. A., Hossain, M. A., Myaux, J., Khan, E. H., Chakraborty, J., Henry, F. & Ronsmans, C.: Antimicrobial resistance of Shigella isolates in Bangladesh, 1983-1990: Increasing frequency of strains multiply resistance to ampicillin, trimethoprim-sulfamethoxazole, and nalidixic acid. Clin. Infect. Dis. 14: 1055-1060, 1992.
8. Brito-Alayon, N. E., Blando, A. M. & Monzon-Moreno, C.: Antibiotic resistance patterns and plasmid profiles for Shigella spp. isolated in Cordoba, Argentina. J. Antimicrob. Chemother. 34: 253-259, 1994.
9. Cavallo, J. D., Bercion, R., Baudet, J. M., Samson, T., France, M. & Meyran, M.: Etude de la sensibilité aux antibiotiques de 140 souches de Shigelles isolées à Djibouti. Bull. Soc. Path. Ex. 86: 35-40, 1993.
10. Farmer III, J. J. & Kelly, M. T.: Enterobacteriaceae. In: Balows, A., Hausler, Jr W. J., Herrmann, K. L., Isenberg, H. D. & Shadomy, H. J. (Eds.): Manual of Clinical Microbiology. American Society for Microbiology, Washington DC 1991, pp. 360-383.
11. Green, M. S., Block, C., Cohen, D. & Slater, P.: Four decades of shigellosis in Israel - the epidemiology of a growing public health problem. Rev. Infect. Dis. 13: 248-253, 1991.
12. Haltalin, K. C., Nelson, J. D., Ring, R., Sladoje, M. & Hinton, L. V.: Double blind treatment study of shigellosis comparing ampicillin, sulfadiazine and placebo. J. Pediatr. 70: 970-981, 1967.
13. Harnett, N.: High level resistance to trimethoprim, cotrimoxazole and other antimicrobial agents among clinical isolates of Shigella species in Ontario, Canada - an update. Epidemiol. Infect. 109: 463-472, 1992.
14. Leibovici, L., Yahav, J., Mates, A., Linn, S. & Danon, Y. L.: Causes of diarrheal disease in soldiers stationed in Lebanon and in northern Israel. Isr. J. Med. Sci. 20: 364-365, 1984.
15. Lima, A. A. M., Lima, N. L., Pinho, M. C. N., Barros, E. A. Jr., Teixeira, M. J., Martins, M. C. V. & Guerrant, R. L.: High frequency of strains multiply resistant to ampicillin, trimethoprim-sulfamethoxazole, streptomycin, chloramphenicol and tetracycline isolated from patients with shigellosis in northeastern Brasil during the period 1988 to 1993. Antimicrob. Agents Chemother. 39: 256-259, 1995.
16. Ling, J., Kam, K. M., Lam, A. W. & French, G. L.: Susceptibilities of Hong Kong isolates of multiply resistant Shigella spp. to 25 antimicrobial agents, including ampicillin plus sulbactam and the new 4-quinolones. Antimicrob. Agents Chemother. 32: 20-23, 1988.
17. National Committee for Clinical Laboratory Standards 1993. Methods for dilution of antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A3. National Committee for Clinical Laboratory Standards, Villanova, PA.
18. Neu, H. C.: In vitro activity of a new broad spectrum beta lactamase-stable oral cephalosporin, cefixime. Pediatr. Infect. Dis. J. 6: 958-962, 1987.
19. Normark, S., Lindquist, S. & Lindberg, F.: Chromosomal beta-lactam resistance in enterobacteria. Scand. J. Infect. Dis. 49 (Suppl.): S38-S45, 1986.
20. Olukoya, D. K. & Oni, O.: Plasmid profile analysis and antimicrobial susceptibility patterns of shigella isolates from Nigeria. Epidemiol. Infect. 105: 59-64, 1990.
21. Prince, A. & Neu, H. C.: Beta-lactamase activity in Shigella sonnei. Antimicrob. Agents Chemother. 9: 776-779, 1976.
22. Quellette, M., Bissonnette, L. & Roy, P. H.: Precise insertion of antibiotic resistance determinants into Tn21-like transposons: Nucleotide sequence of the OXA-1 beta-lactamase gene. Proc. Natl. Acad. Sci. USA. 84: 7378-7382, 1987.
23. Rogerie, F., Ott, D., Vandepitte, J., Verbist, L., Lemmens, P. & Habiyaremye, I.: Comparison of norfloxacin and nalidixic acid for treatment of dysentery caused by Shigella dysenteriae Type 1 in adults. Antimicrob. Agents Chemother. 29: 883-886, 1986.
24. Salam, M. A. & Bennish, M. L.: Antimicrobial therapy for shigellosis. Rev. Infect. Dis. 13: (Suppl. 4): S332-S341, 1991.
25. Samonis, G., Elting, L., Skoulika, E., Maraki, S. & Tselentis, Y.: An outbreak of diarrhoeal disease attributed to Shigella sonnei. Epidemiol. Infect. 112: 235-245, 1994.
26. Shawar, R., LaRocco, M. & Cleary, T. G.: Comparative in vitro activity of cefibuten (Sch 39720) against bacterial enteropathogens. Antimicrob. Agents Chemother. 33: 781-784, 1989.
27. Schumacher, H., Nir, M., Mansa, B. & Grassy, A.: β-lactamases in Shigella. APMIS 100: 954-956, 1992.
28. Suzuki, S., Nakazawa, S. & Ushioda, T.: Yearly changes of drug resistance of shigella strains isolated in Kyoto for five years from 1951. Chemotherapy 4: 336-340, 1986.
29. Tong, M. J., Martin, D. G., Cunningham, J. J. & Gunning, J. J.: Clinical and bacteriological evaluation of antibiotic treatment in shigellosis. JAMA 214: 1841-1844, 1970.
30. Versano, I., Eidlitz-Marcus, T., Nussinovitch, M. & Elian, I.: Comparative efficacy of ceftriaxone and ampicillin for treatment of severe shigellosis in children. J. Pediatr. 118: 627-632, 1991.
31. Vila, J., Gascon, J., Abdalla, S., Gomez, J., Marco, F., Moreno, A., Corachan, M. & Jimenez de Anta, T.: Antimicrobial resistance of Shigella isolates causing traveler's diarrhea. Antimicrob. Agents Chemother. 38: 2668-2670, 1994.
32. Voogd, C. E., Schot, C. S., van Leeuwen, W. J. & van Klingeren, B.: Monitoring of antibiotic resistance in shigellae isolated in the Netherlands, 1984-1989. Eur. J. Clin. Microbiol. Infect. Dis. 11: 164-167, 1992.